The population impact of HPV/cytology cervical cotesting at 3-year intervals: reduced cervical cancer risk and decreased yield of precancer per screen

BACKGROUND: Cervical screening aims to detect and treat precancer to prevent cervical cancer mortality and morbidity, while minimizing overtreatment of benign human papillomavirus (HPV) infections and related minor abnormalities. HPV/cytology cotesting at extended 5-year intervals is now a recommend...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer
Hauptverfasser: Silver, Michelle I., Schiffman, Mark, Fetterman, Barbara, Poitras, Nancy, Gage, Julia C., Wentzensen, Nicolas, Lorey, Thomas, Kinney, Walter, Castle, Philip E.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2016
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5115944/
https://ncbi.nlm.nih.gov/pubmed/27657992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30277
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge